Name

Zanolimumab

Alternate Names

HU-MAX-CD4
HuMax CD4
HuMax-CD4

Abbreviations

None

Category

Biologic therapy (BRM, immunotherapy)

Subcategory

Monoclonal antibody

NSC Number

None

Primary Site

Cutaneous T-cell lymphoma
mycosis fungoides

Histology

None

Remarks

Phase III Amgen, Genmab. Orphan drug, fast-track status. Targets CD4 receptor on T-cells.

Coding

This drug should be coded
Glossary